Mr. Chairman, let me make several points in closing, if I could. First of all, let me reiterate to my colleague what the gentleman from Colorado [Mr. Schaefer] said, that fundamentally we made a decision in this Congress just 3 years ago that we would make an important transition from an era of fossil fuel to an era that included Federal funding for new emerging renewable technologies. That was just 3 years ago. And the choice now is as I think a number of my colleagues on the other side, the gentleman from Massachusetts [Mr. Markey], the gentleman from Massachusetts [Mr. Kennedy], the gentleman from California [Mr. Fazio] have pointed out, here we find a situation where this bill continues to fund substantial amounts of money for coal research which we have been doing for 60 years, nuclear research which we have been doing for 40 years, and while it is true those programs are cut, they are not cut as dramatically as the renewable program under the markup we now find ourselves in from the committee. Finally, again, if I could say this one more time, this is not a vote about solar. This is a vote about renewables. That includes wind. It includes other technologies as well as solar technology. And finally, to primarily my Republican colleagues, let me assure them this does not add to the deficit.
Scott Klug: “Mr. Chairman, let me make several points in closing, if I could. First of all, let me reiterate to my colleague what the…”
Editor's note · Context
Discussing funding for renewable energy technologies during a committee meeting.
Share
More from Scott Klug
let me make a fundamental point in all of this, and that is the fact that even though Washington occasionally promises us that they are going to get waivers, they wait. This is an indication that right now there are 28 welfare waivers…
The Appalachian Regional Commission was set up in 1965 under the premise that if we poured more money from the Federal Government into this area we would get an economic boom. Now I think there is a flaw in this argument, because clearly…
I want to go back, because I do not think we can stress this often enough, to what is at stake in FDA reform, period. Because you managed, Mr. Greenwood, at the end of your conversation with Mr. Barton, I think, to put a very human face on…
We have a very important fundamental choice before us today. To what degree do we trust the citizens of Wisconsin to make their own decision about welfare reform and to what degree do we think that Wisconsin's plan needs to be modified…





